Retinal Müller Glia Alterations and Ocular Glymphatic Clearance in an Alzheimer's Disease Mouse Model

These findings reinforce and expand on prior evidence that Müller glial cell (MGC) biology undergoes significant changes in the early stages of AD, potentially preceding clinical symptoms. The identification of the peripheral retina as a critical yet underexplored region in understanding retinal AD pathology highlights its potential as an accessible biomarker and a potential target for early intervention. Further research will dissect the complex interplay between local Aβ production and clearance to clarify the retina's role in AD progression, paving the way for novel diagnostic and therapeutic strategies.